- Home
- RAPT vs MRBK Comparison
RAPT vs MRBK Comparison
Compare RAPT & MRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- MRBK
- Stock Information
- Founded
- RAPT 2015
- MRBK 2004
- Country
- RAPT United States
- MRBK United States
- Employees
- RAPT N/A
- MRBK N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- MRBK Major Banks
- Sector
- RAPT Health Care
- MRBK Finance
- Exchange
- RAPT Nasdaq
- MRBK Nasdaq
- Market Cap
- RAPT 122.9M
- MRBK 145.8M
- IPO Year
- RAPT 2019
- MRBK 2017
- Fundamental
- Price
- RAPT $13.31
- MRBK $14.87
- Analyst Decision
- RAPT Buy
- MRBK Buy
- Analyst Count
- RAPT 5
- MRBK 2
- Target Price
- RAPT $36.75
- MRBK $17.00
- AVG Volume (30 Days)
- RAPT 133.4K
- MRBK 135.8K
- Earning Date
- RAPT 08-07-2025
- MRBK 07-24-2025
- Dividend Yield
- RAPT N/A
- MRBK 3.36%
- EPS Growth
- RAPT N/A
- MRBK 69.83
- EPS
- RAPT N/A
- MRBK 1.61
- Revenue
- RAPT N/A
- MRBK $106,330,000.00
- Revenue This Year
- RAPT N/A
- MRBK $22.49
- Revenue Next Year
- RAPT N/A
- MRBK $9.50
- P/E Ratio
- RAPT N/A
- MRBK $9.25
- Revenue Growth
- RAPT N/A
- MRBK 17.11
- 52 Week Low
- RAPT $5.67
- MRBK $10.04
- 52 Week High
- RAPT $27.84
- MRBK $17.33
- Technical
- Relative Strength Index (RSI)
- RAPT 69.39
- MRBK 66.63
- Support Level
- RAPT $10.00
- MRBK $14.44
- Resistance Level
- RAPT $14.09
- MRBK $15.08
- Average True Range (ATR)
- RAPT 1.04
- MRBK 0.44
- MACD
- RAPT 0.42
- MRBK 0.08
- Stochastic Oscillator
- RAPT 87.32
- MRBK 70.93
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About MRBK Meridian Corporation
Meridian Corp is a bank holding company. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal, business lending, and deposit services. It operates in three reportable segments including Bank, Wealth, and Mortgage. The company generates maximum revenue from the Bank segment which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans.